FibroGen (Mexico) Analysis
| FGEN Stock | MXN 7.90 0.04 0.50% |
FibroGen is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of FibroGen stock analysis is to determine its intrinsic value, which is an estimate of what FibroGen is worth, separate from its market price. There are two main types of FibroGen's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect FibroGen's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of FibroGen's stock to identify patterns and trends that may indicate its future price movements.
The FibroGen stock is traded in Mexico on Mexican Exchange, with the market opening at 08:30:00 and closing at 15:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Mexico. FibroGen Stock trading window is adjusted to America/Mexico City timezone.
FibroGen |
FibroGen Stock Analysis Notes
About 79.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 62.14. FibroGen had not issued any dividends in recent years. FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company was incorporated in 1993 and is headquartered in San Francisco, California. FibroGen operates under Biotechnology classification in Mexico and is traded on Mexico Stock Exchange. It employs 461 people. To learn more about FibroGen call Enrique Conterno at 415 978 1200 or check out https://www.fibrogen.com.FibroGen Investment Alerts
| FibroGen had very high historical volatility over the last 90 days | |
| FibroGen has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 235.31 M. Net Loss for the year was (290.02 M) with loss before overhead, payroll, taxes, and interest of (104.61 M). | |
| FibroGen has accumulated about 565.4 M in cash with (82.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.56. | |
| Over 79.0% of the company shares are owned by institutional investors |
FibroGen Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 43.36 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate FibroGen's market, we take the total number of its shares issued and multiply it by FibroGen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.FibroGen Profitablity
FibroGen's profitability indicators refer to fundamental financial ratios that showcase FibroGen's ability to generate income relative to its revenue or operating costs. If, let's say, FibroGen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, FibroGen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of FibroGen's profitability requires more research than a typical breakdown of FibroGen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (2.94) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.52) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.52. Technical Drivers
As of the 29th of November, FibroGen shows the Downside Deviation of 9.02, mean deviation of 2.17, and Semi Deviation of 3.54. FibroGen technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.FibroGen Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. FibroGen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for FibroGen. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
FibroGen Predictive Daily Indicators
FibroGen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of FibroGen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 7.9 | |||
| Day Typical Price | 7.9 | |||
| Price Action Indicator | (0.02) | |||
| Period Momentum Indicator | (0.04) | |||
| Relative Strength Index | 60.22 |
FibroGen Forecast Models
FibroGen's time-series forecasting models are one of many FibroGen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary FibroGen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About FibroGen Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how FibroGen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling FibroGen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as FibroGen. By using and applying FibroGen Stock analysis, traders can create a robust methodology for identifying FibroGen entry and exit points for their positions.
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company was incorporated in 1993 and is headquartered in San Francisco, California. FibroGen operates under Biotechnology classification in Mexico and is traded on Mexico Stock Exchange. It employs 461 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding FibroGen to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Additional Tools for FibroGen Stock Analysis
When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.